3 blockbuster ASX blue chip shares to buy

CSL Limited (ASX:CSL) and these ASX 200 blue chip shares could be blockbuster buys for investors…

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

If you're interested in adding some blue chips to your portfolio then I would suggest you consider the three listed below.

Here's why I think they are quality options for blue chip investors:

Cochlear Limited (ASX: COH)

I think Cochlear is a blue chip share to consider buying due to the ageing populations tailwind. As people age, their hearing will tend to fade and require some assistance. I expect this to lead to increasing demand for hearing solutions products over the next couple of decades. And thanks to Cochlear's high quality products, its wide distribution network, and high level of investment in R&D, I expect it to stay ahead of its rivals. Though, it is worth noting that the coronavirus pandemic will inevitably reduce sales in the short term due to the deferring of elective surgeries. But hearing doesn't suddenly improve. These missed sales will be back.

Coles Group Ltd (ASX: COL)

This supermarket operator could be a great option for investors looking at blue chips. Although its shares have been strong performers in 2020, I still think they are good value for a long-term investment. Especially considering its defensive qualities, solid growth prospects, and attractive dividend policy. In respect to its growth, I believe Coles' focus on cost cutting through automation and efficiencies will underpin solid earnings growth over the next decade.

CSL Limited (ASX: CSL)

I think the biotherapeutics company is the best buy and hold blue chip option on the local market. This is due to its high quality CSL Behring and Seqirus businesses. CSL Behring is the global leader in plasma therapies and Seqirus is the second biggest player in the influenza vaccines industry. Both businesses have outstanding long-term growth prospects due to their leading therapies and lucrative development pipelines. Another positive is the strong demand for immunoglobulins and the increasing utilisation for secondary immunodeficiencies. And while the coronavirus pandemic could impact plasma collections, I expect these to rebound strongly once conditions return to normal. Especially given how higher unemployment usually supports donations.

James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of Cochlear Ltd. and CSL Ltd. The Motley Fool Australia has recommended Cochlear Ltd. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on ⏸️ ASX Shares

a woman wearing a close-sitting hat featuring wires and thick computer screen glasses clutches her computer monitor and looks shocked and disturbed as she reads old-fashioned computer text from the screen.
Technology Shares

Here's why ASX 200 tech shares (ASX:XTX) outperformed today

ASX tech shares have taken a turn for the better today.

Read more »

Worker in hard hat looks puzzled with one hand on chin
Resources Shares

Why did the Rio Tinto share price (ASX:RIO) have such a lousy 2021?

We look at what happened to this ASX 200 mining giant's shares last year

Read more »

a miner wearing a hard hat smiles as he stands in front of heavy earth moving equipment on a barren mine site.
Share Gainers

Here's why the Rumble Resources (ASX:RTR) share price is climbing 5%

The mineral explorer's share price is on the rise amid promising drill results.

Read more »

share price high, all time record, record share price, highest, price rise, increase, up,
⏸️ ASX Shares

Here are the top 10 ASX 200 shares on Wednesday

Here are your top 10 biggest gainers in the ASX 200 on Wednesday.

Read more »

comical investor reading documents and surrounded by calculators
⏸️ ASX Shares

The ASX reporting wrap-up: WiseTech, Bravura, Seven Group

Just what the investor ordered. Here’s a recap of the companies that reported on Wednesday...

Read more »

Doctor performing an ultrasound on pregnant woman
⏸️ ASX Shares

The ASX reporting wrap-up: Ansell, Kogan, Nanosonics

Just what the investor ordered. Here’s a recap of the companies that reported on Tuesday...

Read more »

blue arrows representing a rising share price ASX 200
⏸️ ASX Shares

Here are the top 10 ASX 200 shares on Tuesday

Here are your top 10 biggest gainers in the ASX 200 on Tuesday.

Read more »

unhappy investor considering computer screen
Share Market News

The ASX reporting wrap-up: Charter Hall, Ampol, NIB Holdings

Just what the investor ordered. Here’s a recap of the companies that reported on Monday...

Read more »